top of page
We are a Houston-based biotech company developing safe and effective drugs that selectively target new mechanisms-of-action to reverse age-related muscle weakness (sarcopenia), Type 2 diabetes, obesity, and muscular dystrophies.
Business Advisory Board
Ridgeline Therapeutics’ Business Advisory Board is comprised of leading senior executives and early-stage investors with highly successful records at moving therapeutic biotech companies to clinical trials, IPOs, and/or exit deals.
bottom of page